Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.03 USD | -1.79% | -2.11% | +40.89% |
May. 09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 64.88M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.63
x | P/E ratio 2025 * |
-3.17
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.25% |
Latest transcript on Lantern Pharma Inc.
1 day | -1.79% | ||
1 week | -2.11% | ||
Current month | +18.24% | ||
1 month | +4.51% | ||
3 months | +45.65% | ||
6 months | +49.63% | ||
Current year | +40.89% |
Managers | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
David Margrave
DFI | Director of Finance/CFO | 64 | 18-05-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
Director/Board Member | 73 | 22-06-07 | |
Donald Keyser
CHM | Chairman | 71 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 6.03 | -1.79% | 44,056 |
24-05-16 | 6.14 | -3.00% | 44,239 |
24-05-15 | 6.33 | +2.26% | 86,064 |
24-05-14 | 6.19 | +1.64% | 64,232 |
24-05-13 | 6.09 | -1.14% | 50,748 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.89% | 64.88M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- LTRN Stock